Dual therapeutic utility of proteasome modulating agents for pharmaco-gene therapy of the cystic fibrosis airway.
about
Adeno-associated virus for cystic fibrosis gene therapyGeneration of novel AAV variants by directed evolution for improved CFTR delivery to human ciliated airway epithelium.Nanodelivery in airway diseases: challenges and therapeutic applications.A shortened adeno-associated virus expression cassette for CFTR gene transfer to cystic fibrosis airway epithelia.Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosisProtein processing and inflammatory signaling in Cystic Fibrosis: challenges and therapeutic strategies.Unique biologic properties of recombinant AAV1 transduction in polarized human airway epithelia.Species-specific differences in mouse and human airway epithelial biology of recombinant adeno-associated virus transduction.Optimization of Recombinant Adeno-Associated Virus-Mediated Expression for Large Transgenes, Using a Synthetic Promoter and Tandem Array EnhancersBioelectric properties of chloride channels in human, pig, ferret, and mouse airway epithelia.Identification and Validation of Small Molecules That Enhance Recombinant Adeno-associated Virus Transduction following High-Throughput Screens.Biological Differences in rAAV Transduction of Airway Epithelia in Humans and in Old World Non-human Primates.A novel chimeric adenoassociated virus 2/human bocavirus 1 parvovirus vector efficiently transduces human airway epithelia.Sensitivity of chloride efflux vs. transepithelial measurements in mixed CF and normal airway epithelial cell populations.Cystic fibrosis gene therapy: successes, failures and hopes for the future.High-content functional screen to identify proteins that correct F508del-CFTR function.Adeno-Associated Virus (AAV) gene therapy for cystic fibrosis: current barriers and recent developments.Comparative biology of rAAV transduction in ferret, pig and human airway epithelia.
P2860
Q26823156-0D27BD7B-09E2-4DD6-BCBE-B8C7F747ACD4Q33482133-D23965EE-B7CB-45BC-A1AA-8B12E01BA8D4Q33483926-6B14D587-BEC5-448B-9B42-158D2969303DQ33864423-8FD44E9A-0117-4C79-87F4-8959C15F3141Q34198852-61726AB0-EA03-4E1C-B382-640FE87500EDQ35043552-79ECDC35-4410-4F9F-8082-9059B5A2BFC2Q35239472-866E6AB4-22BD-42B0-8D5E-17326352D194Q35546541-80B7F9BF-CB43-4B6C-997A-EB16184A2D8FQ35821858-15215768-F031-4DE2-A4D9-5F6586F2D56BQ35847294-B46C5101-FC19-49CE-88BC-5DC1B467111DQ36009041-36440993-3C8E-4F6B-9E40-ECD0770649DAQ36238758-679D825B-C644-4417-82C4-9FC784674D45Q37393822-89FB2169-766B-4A21-A575-ED6901EE7F69Q39271144-505094E9-1770-4D20-BCD5-EBA7E2B16905Q39872579-06C3CDA1-769A-4F9C-9CC7-9C8F6A84CF3AQ39904574-1A42DB99-7A84-46CA-A296-B4A52E613FF7Q40142907-90B6C3C9-4CDC-43AB-A3D4-FE1ADF0B84C6Q42632053-400B27D7-5DFD-4C83-8B47-243139CE5A5C
P2860
Dual therapeutic utility of proteasome modulating agents for pharmaco-gene therapy of the cystic fibrosis airway.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Dual therapeutic utility of pr ...... of the cystic fibrosis airway.
@en
Dual therapeutic utility of pr ...... of the cystic fibrosis airway.
@nl
type
label
Dual therapeutic utility of pr ...... of the cystic fibrosis airway.
@en
Dual therapeutic utility of pr ...... of the cystic fibrosis airway.
@nl
prefLabel
Dual therapeutic utility of pr ...... of the cystic fibrosis airway.
@en
Dual therapeutic utility of pr ...... of the cystic fibrosis airway.
@nl
P2093
P50
P1433
P1476
Dual therapeutic utility of pr ...... of the cystic fibrosis airway
@en
P2093
Barrie Carter
Charles W Caldwell
Christopher J Gerard
Douglas Laux
Eric Pastor
Huidong Shi
Keith Munson
Richard Peluso
Simon Godwin
P304
P356
10.1016/J.YMTHE.2004.08.009
P577
2004-12-01T00:00:00Z